1. Home
  2. RAND vs TXMD Comparison

RAND vs TXMD Comparison

Compare RAND & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rand Capital Corporation

RAND

Rand Capital Corporation

HOLD

Current Price

$11.06

Market Cap

31.7M

Sector

Finance

ML Signal

HOLD

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.35

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAND
TXMD
Founded
1969
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.7M
25.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RAND
TXMD
Price
$11.06
$2.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.8K
98.0K
Earning Date
03-09-2026
03-26-2026
Dividend Yield
10.49%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$7,327,287.00
$2,796,000.00
Revenue This Year
N/A
$427.09
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$90.45
Revenue Growth
N/A
75.19
52 Week Low
$10.05
$0.72
52 Week High
$31.89
$2.95

Technical Indicators

Market Signals
Indicator
RAND
TXMD
Relative Strength Index (RSI) 43.60 56.98
Support Level $10.48 $2.12
Resistance Level $11.15 $2.45
Average True Range (ATR) 0.34 0.23
MACD 0.07 -0.01
Stochastic Oscillator 67.14 39.08

Price Performance

Historical Comparison
RAND
TXMD

About RAND Rand Capital Corporation

Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: